Preview

Ophthalmology in Russia

Advanced search

MONITORING OF FUNCTIONAL PARAMETERS IN THE PATIENTS WITH EARLY STAGE OF AGE-RELATED MACULAR DEGENERATION

https://doi.org/10.18008/1816-5095-2017-3-260-267

Abstract

Purpose: clinical monitoring of functional parameters in patients with early stage of age-related macular degeneration (AMD) receiving the dietary supplement Retinorm. Patients and methods: clinical monitoring was conducted during 5 months in 40 patients aged 42–75 years with AMD-manifestations in the form of dry drusen and pigment epithelium defects typed as «geographic atrophy». The main group (20 subjects, 35 eyes) received dietary supplement Retinorm (1 capsule 3 times daily for two months with a month break and repeated admission rate, similar to the first). Patients also received instillations of Visomitin® with3 time daily by such mode: using of instillations 2 months, 1 month break, after that — continuation of instillations during 2 months. The control group (20 subjects, 34 eyes) received only Visomitin® instillations 3 times daily by the same scheme as group I. Checking of visual acuity with maximal correction, static computer perimetry, the optical coherent tomography of retina central area, definition of critical flicker frequency (CFF), retinal electrical sensitivity and optic nerve electrical lability were used as the examination methods. Results: Indicated therapy in the main group improved the monitored functional parameters. Increase of uncorrected visual acuity and the best corrected visual acuity, decrease of relative and absolute scotomas amount in central area of the visual field, increasing of CFF (p<0,05) and tendency to increasing of electrical lability (p<0,5) and lowering the threshold electrical sensitivity (p<0,2) were obtained. The changes of the pointed parameters in the control group were irrelevant and unreliable. Conclusions: The findings suggest a positive effect of Retinorm for the neurosensory cells of retina and for metabolism of the crystalline lens, which contributes to the stabilization of the pathological process in AMD and initial senile cataract. Supplement Retinorm can be recommended for widespread use in patients with early stage-AMD especially in the possible association with initial senile cataract.

About the Authors

I. A. Gndoyan
The Volgograd State Medical University
Russian Federation
MD, professor of ophthalmology department; Pavshih bortsov place, 1, Volgograd, 400161, Russia


A. V. Petrayevsky
The Volgograd State Medical University
Russian Federation
MD, professor, head of ophthalmology department; Pavshih bortsov place, 1, Volgograd, 400161, Russia


N. A. Kuznetsova
LikontYug medical clinic
Russian Federation
ophthalmologist; Rionskaya st., 4, Volgograd, 400107 e-mail: licont_boss@mail.ru


A. I. Dyatchina
LikontYug medical clinic
Russian Federation
ophthalmologist; Rionskaya st., 4, Volgograd, 400107 e-mail: licont_boss@mail.ru


References

1. Friedman D.S., O’Colmain B.J., Muñoȥ B. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Ach. Ophthalmol. 2004;122(4):564-572. DOI:10.1001/archopht.122.4.564

2. Будзинская М.В., Воробьева М.В., Киселева Т.Н., Лагутина Ю.М., Полунин Г.С. Современные подходы к лечению и профилактике возрастной макулярной дегенерации. Клиническая офтальмология. 2007;8(2):78-82. [Budzinskaya M.V., Vorobeva M.V., Kiseleva T.N., Lagutina Yu.M., Polunin G.S. Current approaches to treatment and prevention of age related macular degeneration. Clinical ophthalmology=Klinicheskaya oftalmologiya. 2007;8(2):78-82.(in Russ).]

3. Wang J.J., Rochtchina E., Lee A.J. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. Ophthalmology. 2007;114:92-98. DOI: http://dx.doi.org/10.1016/j.ophtha.2006.07.017

4. Нероев В.В., Лантух Е.П., Зуева М.В., Цапенко И.В., Фролов М.А., Рябина М.В., Гончар П.А. Электроретинография у больных с неэкссудативной возрастной макулярной дегенерацией. Российский офтальмологический журнал. 2013;6(3):48-53. [Neroyev V.V.. Lantukh E.P.. Zuyeva M.V.. Tsapenko I.V.. Frolov M.A.. Ryabina M.V.. Gonchar P.A. Electroretinography in patients with non-exudative age-related macular degeneration. Russian ophthalmologic journal=Rossiyskiy oftalmologicheskiy zhurnal. 2013;6(3):48-53. (in Russ.)]

5. Егоров В.В., Гохуа Т.И., Смолякова Г.П., Данилова Л.П., Еманова Л.П., Жайворонок Н.С. Дальневосточные природные фитоминеральные средства в лечении заболеваний глаз. Часть I. Использование дальневосточного фитоминерального средства Ламифарен в лечении возрастной макулярной дегенерации сетчатки. Клиническая офтальмология. 2012;13(2):74-77. [Egorov V.V.. Gokhua T.I.. Smolyakova G.P.. Danilova L.P.. Emanova L.P.. Zhayvoronok N.S. Far East natural fitomineral remedies in eye diseases treatment. Part I. Using Far East fitomineral remedy Lamifaren in the treatment of age-related macular degeneration of the retina. Clinical ophthalmology=Klinicheskaya oftalmologiya. 2012;13(2):7477. (in Russ.)]

6. Ермакова Н.А., Рабданова О.Ц. Основные этиологические факторы и патогенетические механизмы развития возрастной макулярной дегенерации. Клиническая офтальмология. 2007;8(3):125-128. [Ermakova N.A.. Rabdanova O.Ts. [The main etiologic factors and pathogenetic mechanisms of age-related macular degeneration development. Clinical ophthalmology=Klinicheskaya oftalmologiya. 2007;8(3):125-128. (in Russ.)]

7. Егоров Е.А., Романенко И.А. Возрастная макулярная дегенерация. Во просы патогенеза, диагностики и лечения. Клиническая офтальмология. 2009;10(1):42-45. [Egorov E.A., Romanenko I.A. Age-related macular degeneration. The questions of pathogenesis, diagnostics and treatment. Clinical ophthalmology=Klinicheskaya oftalmologiya. 2009;10(1):42-45. (in Russ.)]

8. Киселева Т.Н, Полунин Г.С., Елисеева Э.Г., Лагутина Ю.М., Воробьева М.В. Современные аспекты патогенеза и клиники возрастной макулярной дегенерации. Офтальмология. 2005;2(1):18-23. [Kiseleva T.N, Polunin G.S., Eliseeva EH.G., Lagutina YU.M., Vorob’eva M.V. Current aspects of pathogenesis and clinic of age-related macular degeneration. Ophthalmology=Oftalmologiya. 2005;2(1):1823. (in Russ.)]

9. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report 8. Arch Ophthalmol. 2001;119(10):1417–1436.

10. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005–2015. doi: 10.1001/jama.2013.4997

11. Rosenfeld P.J., Shapiro H., Tuomi L. ANCOR Study Groups. Characteristics of patients loosing vision after 2 years of monthly dosing in the phase II ranibizumab clinical trials. Ophthalmology. 2011;118(3):523-530. DOI: http://dx.doi. org/10.1016/j.ophtha.2010.07.011

12. Liu I.Y, White L., LaCroix A.Z The association of age related macular degeneration and les opacities in aged. Amer.J.Publ.Helth.1989;79(6):765-769.

13. Sperduto R. Lens opacities and senile maculopathy. Arch.Ophthalmol. 1981;99:10041008.

14. Mervat A. A., Eman M. A., Amal I. E.. Effectiveness of selenium on acrylamide toxicity to retina. Int. J. Ophthalmol. 2014;7(4):614–620. doi: 10.3980/j.issn.22223959.2014.04.05

15. Eckhert C.D., Lockwood M.K., Shen B. Influence of selenium on the microvasculature of the retina. Microvasc Res. 1993;45(1):74–82.

16. Еричев В.П., Козлова И.В., Рещикова В.С., Алексеев В.Н., Левко М.А., Замятнин А.А., Гудкова Е.Ю., Ковалева Н.А., Выгодин В.А., Федоркин О.Н., Остапенко В., Сенин И.И., Савченко А.Ю., Попеко Н.А., Скулачев В.П., Скулачев М.В. Клиническое исследование эффективности и безопасности препарата визомитин®, глазные капли, у пациентов с возрастной катарактой. Национальный журнал Глаукома. 2016;15(1):61-69. [Erichev V.P., Kozlova I.V., Reshchikova V.S., Alekseev V.N., Levko M.A., Zamyatnin A.A., Gudkova E.YU., Kovaleva N.A., Vygodin V.A., Fedorkin O.N., Ostapenko V., Senin I.I., Savchenko A.YU., Popeko N.A., Skulachev V.P., Skulachev M.V. Clinical research of effectiveness and safety of visomitin®, eye drops, in senile cataract patients. National Journal Glaucoma=Nacional’nyj zhurnal Glaukoma. 2016;15(1):61-69. (in Russ.)]

17. Голубцов К.В., Куман И.Г., Хейло Т.С., Шигина Н.А., Трунов В.Г., Айду Э.А.-И., Быкова Т.А., Софронов П.Д., Рябцева А.А. Мелькающий свет в диагностике и лечении патологических процессов зрительной системы человека. Информационные системы. 2003; 3(2):114-122. [Golubtsov K.V., Kuman I.G., Hejlo T.S., Shigina N.A., Trunov V.G., Ajdu E.A.-I., Bykova T.A., Sofronov P.D., Ryabtseva A.A. Flicker light in diagnostic and treatment of human visual system pathologies. Information systems=Informatsionnye sistemy. 2003;3(2):114-122. (in Russ.)]

18. Ермакова Н.А. Роль нутрицевтиков в снижении риска прогрессирования возрастной макулярной дегенерации. Офтальмология. 2016;13(3):163-168. [Ermakova N.A. Role of dietary supplementation in preventing progression of agerelated macular degeneration. Ophthalmology=Oftalmologiya. 2016;13(3):163-168. (in Russ.)] DOI: http://dx.doi.org/10.18008/1816-5095-2016-3-163-168

19. Gottsch J. D, Bynoe L. A., Harlan J. B. et al. Light-induced deposits in Bruch’s membrane of protoporphyric mice. Arch. Ophthalmol. 1993;111:126–129.

20. Егоров Е.А. Некоторые аспекты патогенеза и лечения возрастной макулярной дегенерации. Клиническая Офтальмология. 2016;1:46-49. [Egorov E.A. Some aspects of pathogenesis and treatment of age-related macular degeneration. Clinical ophthalmology=Klinicheskaya oftalmologiya. 2016;1:46-49. (in Russ.)]


Review

For citations:


Gndoyan I.A., Petrayevsky A.V., Kuznetsova N.A., Dyatchina A.I. MONITORING OF FUNCTIONAL PARAMETERS IN THE PATIENTS WITH EARLY STAGE OF AGE-RELATED MACULAR DEGENERATION. Ophthalmology in Russia. 2017;14(3):260-267. (In Russ.) https://doi.org/10.18008/1816-5095-2017-3-260-267

Views: 1560


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1816-5095 (Print)
ISSN 2500-0845 (Online)